SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is generating significant community buzz as investors closely monitor potential upcoming lease announcements for their AI data center sites. While market volatility and geopolitical concerns create some pressure, many are focused on the company's large secured power pipeline and the strategic importance of its energy assets for future AI infrastructure.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 ETF (SPY) is trending as traders react to a developing geopolitical peace deal with Iran, with community discussion intensely focused on whether the news serves as a legitimate long-term market catalyst or a temporary manipulation event. Investors are balancing optimism over potential oil supply normalization and index gains against skepticism regarding the deal's finality and pending macroeconomic factors like upcoming Federal Reserve meetings.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is the center of intense market debate as investors grapple with its massive valuation and its debut as a public entity. While proponents point to its dominant position in launch technology and Starlink's potential as long-term infrastructure, skeptics argue the stock is an overhyped bubble driven by institutional forced buying rather than current profitability.

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is trending amid intense debate as supporters anticipate a potential rally driven by speculative market moves and meme coin sentiment, while detractors frequently label the project as a scam. The community remains deeply divided, with many traders closely watching for technical breakouts or institutional catalysts to fuel a reversal.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors remain divided over the sustainability of the AI-driven tech rally, with many traders using it to hedge against high market valuations and potential geopolitical risks. The community is actively debating the timing of a market correction versus the risks of holding leveraged inverse instruments during a persistent bull market.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is experiencing extreme volatility as traders react to conflicting reports regarding a potential peace deal between the U.S. and Iran. The community is deeply divided and skeptical, with many discussing the role of market manipulation and political rhetoric in driving sharp, news-based price swings while regional tensions remain elevated.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing intense debate as investors weigh strong institutional accumulation and robust profit margins against skepticism regarding its advertising model and competition from rivals like Paramount. While some community members remain deeply bearish, predicting further price erosion, others point to the stock's oversold status and structural financial strength as a potential setup for a significant trend reversal.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant attention as investors anticipate the upcoming release of Phase 3 VELA-52 data, which many believe will act as a major valuation catalyst. The community is actively discussing the strategic timing of data releases and potential M&A activity, with heightened focus on management's presence at the upcoming Goldman Sachs conference and recent commercial-readiness milestones.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors digest a capital raise announced alongside positive phase 3 trial data for its hereditary angioedema gene-editing candidate. While community members are debating the impact of the stock offering and the potential for a short squeeze given the significant short interest, many are focused on the long-term potential of the company's in-vivo platform to disrupt the treatment market.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is seeing heightened investor interest as the market anticipates the imminent finalization of its acquisition of Northern Data, a move expected to transform the company into a major AI cloud infrastructure player. Community discussions are heavily focused on the stock's potential for a significant revaluation, fueled by newly secured high-capacity GPU contracts and backing from Tether, while some investors remain frustrated by recent price volatility and communication regarding merger timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is SMMT Stock Tumbling Today?

Equity

Summit announced a common stock offering, with underwriters having a 30-day option to purchase up to an additional $75 million of shares.

CADL Stock Heads For Best Week In A Month – Here’s Why Retail Is Bullish

Candel Therapeutics Phase 3 prostate cancer trial showed a higher disease-free survival rate.

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

VSTM Stock Climbs After-Hours As FDA Grants Fast Track To Lung Cancer Drug — Retail Eyes The Next Keytruda 

The Fast Track designation is designed to help promising medicines for serious diseases reach patients faster by allowing more frequent contact with regulators and potentially quicker review.


ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’

CFO said at a conference that profitability is “right around the corner,” though the company is waiting for more top-line certainty before formal guidance.


VKTX Eyes Worst Week Since November As Trial Data Looms — Wall Street Still Sees 200% Upside

Data readout from the maintenance dosing study of VK2735, the company’s investigational obesity candidate, is expected in the third quarter. 


CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff?

The company reported three deaths in the trial, though none were associated with its experimental drug gedatolisib.


TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside

The licensing deal, announced Tuesday with China’s Everest Medicines, gives Travere exclusive rights to develop and sell the drug civorebrutinib in the United States.


ONCY Stock Heads For Sixth Straight Session Of Gains – Lead Therapy Shines in Early Combination Treatment Study

Oncolytics Biotech said preclinical data showed its experimental immunotherapy produced stronger anti-tumor effects in combination therapy, supporting future studies in pancreatic and colorectal cancers.

XBISPDR S&P Biotech ETF

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest XBI News